Kellie Murphy, MBA, is a BioPharma commercial strategy executive with over 21 years of experience in market access, pricing, and reimbursement. Currently involved with Sanofi, they focus on access strategy for rare diseases while previously leading oncology marketing initiatives at Takeda Oncology and Bristol Myers Squibb. Kellie has successfully launched 17 therapies across various sectors, including orphan drugs and oncology, and is recognized for their innovative approach and commitment to improving patient access. With an MBA in Marketing and Communications from Alvernia University, Kellie combines strategic vision with clinical and operational expertise to drive growth and innovation in the industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices